{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T04:10:26Z","timestamp":1759464626833,"version":"build-2065373602"},"reference-count":6,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1053\/j.ajkd.2022.09.006","type":"journal-article","created":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T10:52:42Z","timestamp":1665226362000},"page":"7-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Social and Financial Implications of Medicare Part B Immunosuppressive Drug Benefits for Kidney Transplant Recipients: A View From the Trenches"],"prefix":"10.1053","volume":"81","author":[{"given":"Jordan C.","family":"Shaffer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roy D.","family":"Bloom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1053\/j.ajkd.2022.09.006_bib5","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1681\/ASN.2021030427","article-title":"Addendum: passage of the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act - a chance to celebrate and reflect","volume":"32","author":"Gill","year":"2021","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2022.09.006_bib7","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ekir.2020.10.011","article-title":"Evaluation of changes over time in the drug burden and medication regimen complexity in ESRD patients before and after renal transplantation","volume":"6","author":"Marienne","year":"2020","journal-title":"Kidney Int Rep"},{"year":"2019","series-title":"Assessing the Costs and Benefits of Extended Medicare Coverage of Immunosuppressive Drugs under Medicare","key":"10.1053\/j.ajkd.2022.09.006_bib8"},{"year":"2022","series-title":"Review Your Self-pay Price Estimate","key":"10.1053\/j.ajkd.2022.09.006_bib9"},{"issue":"suppl 3","key":"10.1053\/j.ajkd.2022.09.006_bib10","article-title":"Are random tacrolimus levels in the emergency department costing you money? [abstract]","volume":"16","author":"Lee","year":"2016","journal-title":"Am J Transplant"},{"year":"2022","series-title":"Lexi-Drugs. Lexicomp","key":"10.1053\/j.ajkd.2022.09.006_bib11"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638622009301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638622009301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T03:46:45Z","timestamp":1759463205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638622009301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":6,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S0272638622009301"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2022.09.006","relation":{},"ISSN":["0272-6386"],"issn-type":[{"type":"print","value":"0272-6386"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Social and Financial Implications of Medicare Part B Immunosuppressive Drug Benefits for Kidney Transplant Recipients: A View From the Trenches","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2022.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}